✦ LIBER ✦

Somatostatin Analogs as Adjuncts to Agonists of Luteinizing Hormone-Releasing Hormone in the Treatment of Experimental Prostate Cancer

✍ Scribed by A. V. Schally and T. W. Redding

Book ID: 123634807
Publisher: National Academy of Sciences
Year: 1987
Tongue: English
Weight: 1014 KB
Volume: 84
Category: Article
ISSN: 0027-8424
DOI: 10.2307/30403

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antagonists of bombesin/gastrin-releasin

Antagonists of bombesin/gastrin-releasing peptide as adjuncts to agonists of luteinizing hormone–releasing hormone in the treatment of experimental prostate cancer

✍ Jacek Pinski; Gabor Halmos; Karoly Szepeshazi; Andrew V. Schally 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 752 KB

Receptors for Prolactin, Somatostatin, a

Receptors for Prolactin, Somatostatin, and Luteinizing Hormone-Releasing Hormone in Experimental Prostate Cancer after Treatment with Analogs of Luteinizing Hormone-Releasing Hormone and Somatostatin

✍ T. Kadar, T. W. Redding, M. Ben-David and A. V. Schally 📂 Article 📅 1988 🏛 National Academy of Sciences 🌐 English ⚖ 787 KB

Luteinizing hormone releasing hormone ag

Luteinizing hormone releasing hormone agonist in the treatment of advanced prostatic cancer

✍ P. Kellokumpu-Lehtinen; R. Valavaara 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Patient compliance in treatment of prost

Patient compliance in treatment of prostate cancer with luteinizing hormone-releasing hormone (LHRH) agonist

✍ J.Anthony Shaheen; Mohammad Amin; James I. Harty 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 311 KB

Chemohormonal therapy as primary treatme

Chemohormonal therapy as primary treatment for metastatic prostate cancer: A randomized study of estramustine phosphate plus luteinizing hormone-releasing hormone agonist versus flutamide plus luteinizing hormone-releasing hormone agonist

✍ MASANORI NOGUCHI; SHINSHI NODA; MASAKI YOSHIDA; SHOICHI UEDA; TAIZO SHIRAISHI; K 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

Bone fractures associated with luteinizi

Bone fractures associated with luteinizing hormone-releasing hormone agonists used in the treatment of prostate carcinoma

✍ Murphy F. Townsend; W. Holt Sanders; Robert O. Northway; Sam D. Graham Jr. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 2 views

## Background: Luteinizing hormone-releasing hormone agonists (lhrh-a) have become an established treatment for certain patients with prostate carcinoma. lhrh-a are known to decrease bone mineral density. the purpose of this study was to determine the risk of bone fracture in men receiving lhrh-a f